XRCC1 Genetic Polymorphism Arg399Gln and Gastric Cancer Risk: A Meta-Analysis

Jian Geng,You-Wei Zhang,Gui-Chun Huang,Long-Bang Chen
DOI: https://doi.org/10.3748/wjg.14.6733
2008-01-01
Abstract:AIM:To evaluate the association between X-ray crosscomplementing gene 1 (XRCC1) genetic polymorphism Arg399Gln and gastric cancer risk by means of metaanalysis. METHODS:We searched PubMed and NCBI up to June 1, 2008.A total of 16 clinical trials and reports were identified, but only 8 trials qualified under our selection criteria.Statistical analysis was performed with the software program Review Manage, version 4.2.8.RESULTS: Of the 8 case-control studies selected for this meta-analysis, a total of 1334 gastric cancer cases and 2194 controls were included.For Arg399Gln, the Gln/Gln genotype carriers did not have a decreased cancer risk compared with those individuals with the Arg/Arg genotype (OR = 0.92, 95% CI, 0.71-1.19;P = 0.51).Similarly, no associations were found in the recessive and dominant modeling (Gln/Gln vs Arg/Gln + Arg/Arg: OR = 0.96; 95% CI, 0.77-1.19;P = 0.70 and Gln/Gln + Arg/Gln vs Arg/Arg: OR = 0.90, 95% CI, 0.77-1.05;P = 0.18). CONCLUSION:No association is found between the XRCC1 polymorphism Arg399Gln and gastric cancer risk.
What problem does this paper attempt to address?